mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.1 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.1 |